These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25483631)

  • 1. Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India.
    Kar SK; Pach A; Sah B; Kerketta AS; Patnaik B; Mogasale V; Kim YH; Rath SB; Shin S; Khuntia HK; Bhattachan A; Puri MK; Wierzba TF; Kaljee LM
    Hum Vaccin Immunother; 2014; 10(10):2834-42. PubMed ID: 25483631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
    Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India.
    Mogasale V; Kar SK; Kim JH; Mogasale VV; Kerketta AS; Patnaik B; Rath SB; Puri MK; You YA; Khuntia HK; Maskery B; Wierzba TF; Sah B
    PLoS Negl Trop Dis; 2015; 9(9):e0004072. PubMed ID: 26352143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.
    Sundaram N; Schaetti C; Merten S; Schindler C; Ali SM; Nyambedha EO; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
    BMC Public Health; 2016 Jan; 16():36. PubMed ID: 26762151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    Semá Baltazar C; Rafael F; Langa JPM; Chicumbe S; Cavailler P; Gessner BD; Pezzoli L; Barata A; Zaina D; Inguane DL; Mengel MA; Munier A
    PLoS One; 2018; 13(10):e0198592. PubMed ID: 30281604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships.
    Odevall L; Hong D; Digilio L; Sahastrabuddhe S; Mogasale V; Baik Y; Choi S; Kim JH; Lynch J
    Vaccine; 2018 Oct; 36(45):6606-6614. PubMed ID: 30314912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
    Démolis R; Botão C; Heyerdahl LW; Gessner BD; Cavailler P; Sinai C; Magaço A; Le Gargasson JB; Mengel M; Guillermet E
    Vaccine; 2018 Oct; 36(44):6497-6505. PubMed ID: 29174106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
    Wierzba TF; Kar SK; Mogasale VV; Kerketta AS; You YA; Baral P; Khuntia HK; Ali M; Kim YH; Rath SB; Bhattachan A; Sah B
    Vaccine; 2015 May; 33(21):2463-9. PubMed ID: 25850019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.
    Mogasale V; Ramani E; Wee H; Kim JH
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005124. PubMed ID: 27930668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.
    Schaetti C; Hutubessy R; Ali SM; Pach A; Weiss MG; Chaignat CL; Khatib AM
    BMC Public Health; 2009 Apr; 9():99. PubMed ID: 19351401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Ray A; Sarkar K; Haldar P; Ghosh R
    Vaccine; 2020 Feb; 38 Suppl 1():A184-A193. PubMed ID: 31377080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The history of OCV in India and barriers remaining to programmatic introduction.
    Mogasale V; Kanungo S; Pati S; Lynch J; Dutta S
    Vaccine; 2020 Feb; 38 Suppl 1():A41-A45. PubMed ID: 31982258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.
    Teshome S; Desai S; Kim JH; Belay D; Mogasale V
    Hum Vaccin Immunother; 2018; 14(10):2427-2433. PubMed ID: 29648523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social and cultural determinants of anticipated acceptance of an oral cholera vaccine prior to a mass vaccination campaign in Zanzibar.
    Schaetti C; Chaignat CL; Hutubessy R; Khatib AM; Ali SM; Schindler C; Weiss MG
    Hum Vaccin; 2011 Dec; 7(12):1299-308. PubMed ID: 22108036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, Attitudes, and Practices regarding Diarrhea and Cholera following an Oral Cholera Vaccination Campaign in the Solomon Islands.
    Burnett E; Dalipanda T; Ogaoga D; Gaiofa J; Jilini G; Halpin A; Dietz V; Date K; Mintz E; Hyde T; Wannemuehler K; Yen C
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004937. PubMed ID: 27548678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo.
    Merten S; Schaetti C; Manianga C; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
    BMC Public Health; 2013 Jan; 13():60. PubMed ID: 23339647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016.
    Sauvageot D; Saussier C; Gobeze A; Chipeta S; Mhango I; Kawalazira G; Mengel MA; Legros D; Cavailler P; M'bang'ombe M
    Vaccine; 2017 Sep; 35(38):5194-5200. PubMed ID: 28803712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social and Behavior Change Communication Interventions Delivered Face-to-Face and by a Mobile Phone to Strengthen Vaccination Uptake and Improve Child Health in Rural India: Randomized Pilot Study.
    Johri M; Chandra D; Kone KG; Sylvestre MP; Mathur AK; Harper S; Nandi A
    JMIR Mhealth Uhealth; 2020 Sep; 8(9):e20356. PubMed ID: 32955455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka, Bangladesh.
    Wahed T; Kaukab SS; Saha NC; Khan IA; Khanam F; Chowdhury F; Saha A; Khan AI; Siddik AU; Cravioto A; Qadri F; Uddin J
    BMC Public Health; 2013 Mar; 13():242. PubMed ID: 23509860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.